Canadian study says oral medicine effective in treating Covid-19
Dr Nita Patel, Director of Antibody discovery and Vaccine development, lifts a vial with a potential Covid-19 vaccine at Novavax labs in Gaithersburg, Maryland, on March 20, 2020.
The study results show that colchicine reduced by 21 percent the risk of death or hospitalizations in patients with Covid-19 compared to placebo, the institute said.
Montreal,
A major clinical trial shows that an inflammatory drug called colchicine is effective in treating Covid-19 and reduces the risk of complications from the disease, doctors in Canada said.
